Global Benign Prostatic Hyperplasia Devices Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Benign Prostatic Hyperplasia Devices market size was valued at US$ 372.7 million in 2023. With growing demand in downstream market, the Benign Prostatic Hyperplasia Devices is forecast to a readjusted size of US$ 499.2 million by 2030 with a CAGR of 4.3% during review period.
The research report highlights the growth potential of the global Benign Prostatic Hyperplasia Devices market. Benign Prostatic Hyperplasia Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Benign Prostatic Hyperplasia Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Benign Prostatic Hyperplasia Devices market.
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
Key Features:
The report on Benign Prostatic Hyperplasia Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Benign Prostatic Hyperplasia Devices market. It may include historical data, market segmentation by Type (e.g., Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Benign Prostatic Hyperplasia Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Benign Prostatic Hyperplasia Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Benign Prostatic Hyperplasia Devices industry. This include advancements in Benign Prostatic Hyperplasia Devices technology, Benign Prostatic Hyperplasia Devices new entrants, Benign Prostatic Hyperplasia Devices new investment, and other innovations that are shaping the future of Benign Prostatic Hyperplasia Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Benign Prostatic Hyperplasia Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Benign Prostatic Hyperplasia Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Benign Prostatic Hyperplasia Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Benign Prostatic Hyperplasia Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Benign Prostatic Hyperplasia Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Benign Prostatic Hyperplasia Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Benign Prostatic Hyperplasia Devices market.
Market Segmentation:
Benign Prostatic Hyperplasia Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Benign Prostatic Hyperplasia Devices market?
What factors are driving Benign Prostatic Hyperplasia Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Benign Prostatic Hyperplasia Devices market opportunities vary by end market size?
How does Benign Prostatic Hyperplasia Devices break out type, application?
According to our LPI (LP Information) latest study, the global Benign Prostatic Hyperplasia Devices market size was valued at US$ 372.7 million in 2023. With growing demand in downstream market, the Benign Prostatic Hyperplasia Devices is forecast to a readjusted size of US$ 499.2 million by 2030 with a CAGR of 4.3% during review period.
The research report highlights the growth potential of the global Benign Prostatic Hyperplasia Devices market. Benign Prostatic Hyperplasia Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Benign Prostatic Hyperplasia Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Benign Prostatic Hyperplasia Devices market.
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
Key Features:
The report on Benign Prostatic Hyperplasia Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Benign Prostatic Hyperplasia Devices market. It may include historical data, market segmentation by Type (e.g., Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Benign Prostatic Hyperplasia Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Benign Prostatic Hyperplasia Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Benign Prostatic Hyperplasia Devices industry. This include advancements in Benign Prostatic Hyperplasia Devices technology, Benign Prostatic Hyperplasia Devices new entrants, Benign Prostatic Hyperplasia Devices new investment, and other innovations that are shaping the future of Benign Prostatic Hyperplasia Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Benign Prostatic Hyperplasia Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Benign Prostatic Hyperplasia Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Benign Prostatic Hyperplasia Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Benign Prostatic Hyperplasia Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Benign Prostatic Hyperplasia Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Benign Prostatic Hyperplasia Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Benign Prostatic Hyperplasia Devices market.
Market Segmentation:
Benign Prostatic Hyperplasia Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Transurethral Resection of the Prostate (TURP)
- Transurethral Microwave Therapy (TUMT)
- Transurethral Needle Ablation of the Prostate (TUNA)
- Laser Surgery
- Prostatic Stenting
- Others
- Hospitals and Clinics
- Ambulatory Surgical Centers(ASC)
- Home
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lumenis
- Olympus corporation
- Urologix
- Boston Scientific corporation
- Lisa Laser
- Medifocus
- Neotrac
- ProArc Medical LTD
- Urotech GMBH
What is the 10-year outlook for the global Benign Prostatic Hyperplasia Devices market?
What factors are driving Benign Prostatic Hyperplasia Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Benign Prostatic Hyperplasia Devices market opportunities vary by end market size?
How does Benign Prostatic Hyperplasia Devices break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Benign Prostatic Hyperplasia Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Country/Region, 2019, 2023 & 2030
2.2 Benign Prostatic Hyperplasia Devices Segment by Type
2.2.1 Transurethral Resection of the Prostate (TURP)
2.2.2 Transurethral Microwave Therapy (TUMT)
2.2.3 Transurethral Needle Ablation of the Prostate (TUNA)
2.2.4 Laser Surgery
2.2.5 Prostatic Stenting
2.2.6 Others
2.3 Benign Prostatic Hyperplasia Devices Sales by Type
2.3.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Benign Prostatic Hyperplasia Devices Sale Price by Type (2019-2024)
2.4 Benign Prostatic Hyperplasia Devices Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Ambulatory Surgical Centers(ASC)
2.4.3 Home
2.4.4 Others
2.5 Benign Prostatic Hyperplasia Devices Sales by Application
2.5.1 Global Benign Prostatic Hyperplasia Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Benign Prostatic Hyperplasia Devices Sale Price by Application (2019-2024)
3 GLOBAL BENIGN PROSTATIC HYPERPLASIA DEVICES BY COMPANY
3.1 Global Benign Prostatic Hyperplasia Devices Breakdown Data by Company
3.1.1 Global Benign Prostatic Hyperplasia Devices Annual Sales by Company (2019-2024)
3.1.2 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2019-2024)
3.2 Global Benign Prostatic Hyperplasia Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Benign Prostatic Hyperplasia Devices Revenue by Company (2019-2024)
3.2.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Company (2019-2024)
3.3 Global Benign Prostatic Hyperplasia Devices Sale Price by Company
3.4 Key Manufacturers Benign Prostatic Hyperplasia Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Benign Prostatic Hyperplasia Devices Product Location Distribution
3.4.2 Players Benign Prostatic Hyperplasia Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BENIGN PROSTATIC HYPERPLASIA DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Benign Prostatic Hyperplasia Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Benign Prostatic Hyperplasia Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Benign Prostatic Hyperplasia Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Benign Prostatic Hyperplasia Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Benign Prostatic Hyperplasia Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Benign Prostatic Hyperplasia Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Benign Prostatic Hyperplasia Devices Sales Growth
4.4 APAC Benign Prostatic Hyperplasia Devices Sales Growth
4.5 Europe Benign Prostatic Hyperplasia Devices Sales Growth
4.6 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Growth
5 AMERICAS
5.1 Americas Benign Prostatic Hyperplasia Devices Sales by Country
5.1.1 Americas Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024)
5.1.2 Americas Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024)
5.2 Americas Benign Prostatic Hyperplasia Devices Sales by Type
5.3 Americas Benign Prostatic Hyperplasia Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Benign Prostatic Hyperplasia Devices Sales by Region
6.1.1 APAC Benign Prostatic Hyperplasia Devices Sales by Region (2019-2024)
6.1.2 APAC Benign Prostatic Hyperplasia Devices Revenue by Region (2019-2024)
6.2 APAC Benign Prostatic Hyperplasia Devices Sales by Type
6.3 APAC Benign Prostatic Hyperplasia Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Benign Prostatic Hyperplasia Devices by Country
7.1.1 Europe Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024)
7.1.2 Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024)
7.2 Europe Benign Prostatic Hyperplasia Devices Sales by Type
7.3 Europe Benign Prostatic Hyperplasia Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Benign Prostatic Hyperplasia Devices by Country
8.1.1 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Type
8.3 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia Devices
10.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
10.4 Industry Chain Structure of Benign Prostatic Hyperplasia Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Benign Prostatic Hyperplasia Devices Distributors
11.3 Benign Prostatic Hyperplasia Devices Customer
12 WORLD FORECAST REVIEW FOR BENIGN PROSTATIC HYPERPLASIA DEVICES BY GEOGRAPHIC REGION
12.1 Global Benign Prostatic Hyperplasia Devices Market Size Forecast by Region
12.1.1 Global Benign Prostatic Hyperplasia Devices Forecast by Region (2025-2030)
12.1.2 Global Benign Prostatic Hyperplasia Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Benign Prostatic Hyperplasia Devices Forecast by Type
12.7 Global Benign Prostatic Hyperplasia Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Lumenis
13.1.1 Lumenis Company Information
13.1.2 Lumenis Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Lumenis Main Business Overview
13.1.5 Lumenis Latest Developments
13.2 Olympus corporation
13.2.1 Olympus corporation Company Information
13.2.2 Olympus corporation Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Olympus corporation Main Business Overview
13.2.5 Olympus corporation Latest Developments
13.3 Urologix
13.3.1 Urologix Company Information
13.3.2 Urologix Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Urologix Main Business Overview
13.3.5 Urologix Latest Developments
13.4 Boston Scientific corporation
13.4.1 Boston Scientific corporation Company Information
13.4.2 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Boston Scientific corporation Main Business Overview
13.4.5 Boston Scientific corporation Latest Developments
13.5 Lisa Laser
13.5.1 Lisa Laser Company Information
13.5.2 Lisa Laser Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Lisa Laser Main Business Overview
13.5.5 Lisa Laser Latest Developments
13.6 Medifocus
13.6.1 Medifocus Company Information
13.6.2 Medifocus Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Medifocus Main Business Overview
13.6.5 Medifocus Latest Developments
13.7 Neotrac
13.7.1 Neotrac Company Information
13.7.2 Neotrac Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Neotrac Main Business Overview
13.7.5 Neotrac Latest Developments
13.8 ProArc Medical LTD
13.8.1 ProArc Medical LTD Company Information
13.8.2 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 ProArc Medical LTD Main Business Overview
13.8.5 ProArc Medical LTD Latest Developments
13.9 Urotech GMBH
13.9.1 Urotech GMBH Company Information
13.9.2 Urotech GMBH Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Urotech GMBH Main Business Overview
13.9.5 Urotech GMBH Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Benign Prostatic Hyperplasia Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Country/Region, 2019, 2023 & 2030
2.2 Benign Prostatic Hyperplasia Devices Segment by Type
2.2.1 Transurethral Resection of the Prostate (TURP)
2.2.2 Transurethral Microwave Therapy (TUMT)
2.2.3 Transurethral Needle Ablation of the Prostate (TUNA)
2.2.4 Laser Surgery
2.2.5 Prostatic Stenting
2.2.6 Others
2.3 Benign Prostatic Hyperplasia Devices Sales by Type
2.3.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Benign Prostatic Hyperplasia Devices Sale Price by Type (2019-2024)
2.4 Benign Prostatic Hyperplasia Devices Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Ambulatory Surgical Centers(ASC)
2.4.3 Home
2.4.4 Others
2.5 Benign Prostatic Hyperplasia Devices Sales by Application
2.5.1 Global Benign Prostatic Hyperplasia Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Benign Prostatic Hyperplasia Devices Sale Price by Application (2019-2024)
3 GLOBAL BENIGN PROSTATIC HYPERPLASIA DEVICES BY COMPANY
3.1 Global Benign Prostatic Hyperplasia Devices Breakdown Data by Company
3.1.1 Global Benign Prostatic Hyperplasia Devices Annual Sales by Company (2019-2024)
3.1.2 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2019-2024)
3.2 Global Benign Prostatic Hyperplasia Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Benign Prostatic Hyperplasia Devices Revenue by Company (2019-2024)
3.2.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Company (2019-2024)
3.3 Global Benign Prostatic Hyperplasia Devices Sale Price by Company
3.4 Key Manufacturers Benign Prostatic Hyperplasia Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Benign Prostatic Hyperplasia Devices Product Location Distribution
3.4.2 Players Benign Prostatic Hyperplasia Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BENIGN PROSTATIC HYPERPLASIA DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Benign Prostatic Hyperplasia Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Benign Prostatic Hyperplasia Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Benign Prostatic Hyperplasia Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Benign Prostatic Hyperplasia Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Benign Prostatic Hyperplasia Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Benign Prostatic Hyperplasia Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Benign Prostatic Hyperplasia Devices Sales Growth
4.4 APAC Benign Prostatic Hyperplasia Devices Sales Growth
4.5 Europe Benign Prostatic Hyperplasia Devices Sales Growth
4.6 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Growth
5 AMERICAS
5.1 Americas Benign Prostatic Hyperplasia Devices Sales by Country
5.1.1 Americas Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024)
5.1.2 Americas Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024)
5.2 Americas Benign Prostatic Hyperplasia Devices Sales by Type
5.3 Americas Benign Prostatic Hyperplasia Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Benign Prostatic Hyperplasia Devices Sales by Region
6.1.1 APAC Benign Prostatic Hyperplasia Devices Sales by Region (2019-2024)
6.1.2 APAC Benign Prostatic Hyperplasia Devices Revenue by Region (2019-2024)
6.2 APAC Benign Prostatic Hyperplasia Devices Sales by Type
6.3 APAC Benign Prostatic Hyperplasia Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Benign Prostatic Hyperplasia Devices by Country
7.1.1 Europe Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024)
7.1.2 Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024)
7.2 Europe Benign Prostatic Hyperplasia Devices Sales by Type
7.3 Europe Benign Prostatic Hyperplasia Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Benign Prostatic Hyperplasia Devices by Country
8.1.1 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Type
8.3 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia Devices
10.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
10.4 Industry Chain Structure of Benign Prostatic Hyperplasia Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Benign Prostatic Hyperplasia Devices Distributors
11.3 Benign Prostatic Hyperplasia Devices Customer
12 WORLD FORECAST REVIEW FOR BENIGN PROSTATIC HYPERPLASIA DEVICES BY GEOGRAPHIC REGION
12.1 Global Benign Prostatic Hyperplasia Devices Market Size Forecast by Region
12.1.1 Global Benign Prostatic Hyperplasia Devices Forecast by Region (2025-2030)
12.1.2 Global Benign Prostatic Hyperplasia Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Benign Prostatic Hyperplasia Devices Forecast by Type
12.7 Global Benign Prostatic Hyperplasia Devices Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Lumenis
13.1.1 Lumenis Company Information
13.1.2 Lumenis Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Lumenis Main Business Overview
13.1.5 Lumenis Latest Developments
13.2 Olympus corporation
13.2.1 Olympus corporation Company Information
13.2.2 Olympus corporation Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Olympus corporation Main Business Overview
13.2.5 Olympus corporation Latest Developments
13.3 Urologix
13.3.1 Urologix Company Information
13.3.2 Urologix Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Urologix Main Business Overview
13.3.5 Urologix Latest Developments
13.4 Boston Scientific corporation
13.4.1 Boston Scientific corporation Company Information
13.4.2 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Boston Scientific corporation Main Business Overview
13.4.5 Boston Scientific corporation Latest Developments
13.5 Lisa Laser
13.5.1 Lisa Laser Company Information
13.5.2 Lisa Laser Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Lisa Laser Main Business Overview
13.5.5 Lisa Laser Latest Developments
13.6 Medifocus
13.6.1 Medifocus Company Information
13.6.2 Medifocus Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Medifocus Main Business Overview
13.6.5 Medifocus Latest Developments
13.7 Neotrac
13.7.1 Neotrac Company Information
13.7.2 Neotrac Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Neotrac Main Business Overview
13.7.5 Neotrac Latest Developments
13.8 ProArc Medical LTD
13.8.1 ProArc Medical LTD Company Information
13.8.2 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 ProArc Medical LTD Main Business Overview
13.8.5 ProArc Medical LTD Latest Developments
13.9 Urotech GMBH
13.9.1 Urotech GMBH Company Information
13.9.2 Urotech GMBH Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
13.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Urotech GMBH Main Business Overview
13.9.5 Urotech GMBH Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Benign Prostatic Hyperplasia Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Benign Prostatic Hyperplasia Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Transurethral Resection of the Prostate (TURP)
Table 4. Major Players of Transurethral Microwave Therapy (TUMT)
Table 5. Major Players of Transurethral Needle Ablation of the Prostate (TUNA)
Table 6. Major Players of Laser Surgery
Table 7. Major Players of Prostatic Stenting
Table 8. Major Players of Others
Table 9. Global Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 10. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Table 11. Global Benign Prostatic Hyperplasia Devices Revenue by Type (2019-2024) & ($ million)
Table 12. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2019-2024)
Table 13. Global Benign Prostatic Hyperplasia Devices Sale Price by Type (2019-2024) & (USD/Unit)
Table 14. Global Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 15. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Table 16. Global Benign Prostatic Hyperplasia Devices Revenue by Application (2019-2024)
Table 17. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application (2019-2024)
Table 18. Global Benign Prostatic Hyperplasia Devices Sale Price by Application (2019-2024) & (USD/Unit)
Table 19. Global Benign Prostatic Hyperplasia Devices Sales by Company (2019-2024) & (K Units)
Table 20. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2019-2024)
Table 21. Global Benign Prostatic Hyperplasia Devices Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Company (2019-2024)
Table 23. Global Benign Prostatic Hyperplasia Devices Sale Price by Company (2019-2024) & (USD/Unit)
Table 24. Key Manufacturers Benign Prostatic Hyperplasia Devices Producing Area Distribution and Sales Area
Table 25. Players Benign Prostatic Hyperplasia Devices Products Offered
Table 26. Benign Prostatic Hyperplasia Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Benign Prostatic Hyperplasia Devices Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Benign Prostatic Hyperplasia Devices Sales Market Share Geographic Region (2019-2024)
Table 31. Global Benign Prostatic Hyperplasia Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Benign Prostatic Hyperplasia Devices Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Country/Region (2019-2024)
Table 35. Global Benign Prostatic Hyperplasia Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024) & (K Units)
Table 38. Americas Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2019-2024)
Table 39. Americas Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2019-2024)
Table 41. Americas Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 42. Americas Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 43. APAC Benign Prostatic Hyperplasia Devices Sales by Region (2019-2024) & (K Units)
Table 44. APAC Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2019-2024)
Table 45. APAC Benign Prostatic Hyperplasia Devices Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Benign Prostatic Hyperplasia Devices Revenue Market Share by Region (2019-2024)
Table 47. APAC Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 48. APAC Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 49. Europe Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024) & (K Units)
Table 50. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2019-2024)
Table 51. Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2019-2024)
Table 53. Europe Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 54. Europe Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 55. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024) & (K Units)
Table 56. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 60. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Benign Prostatic Hyperplasia Devices
Table 62. Key Market Challenges & Risks of Benign Prostatic Hyperplasia Devices
Table 63. Key Industry Trends of Benign Prostatic Hyperplasia Devices
Table 64. Benign Prostatic Hyperplasia Devices Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Benign Prostatic Hyperplasia Devices Distributors List
Table 67. Benign Prostatic Hyperplasia Devices Customer List
Table 68. Global Benign Prostatic Hyperplasia Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 69. Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Benign Prostatic Hyperplasia Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Americas Benign Prostatic Hyperplasia Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Benign Prostatic Hyperplasia Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 73. APAC Benign Prostatic Hyperplasia Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Benign Prostatic Hyperplasia Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Europe Benign Prostatic Hyperplasia Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 77. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2025-2030) & (K Units)
Table 81. Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Lumenis Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 83. Lumenis Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 84. Lumenis Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Lumenis Main Business
Table 86. Lumenis Latest Developments
Table 87. Olympus corporation Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 88. Olympus corporation Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 89. Olympus corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Olympus corporation Main Business
Table 91. Olympus corporation Latest Developments
Table 92. Urologix Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. Urologix Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 94. Urologix Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Urologix Main Business
Table 96. Urologix Latest Developments
Table 97. Boston Scientific corporation Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 99. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Boston Scientific corporation Main Business
Table 101. Boston Scientific corporation Latest Developments
Table 102. Lisa Laser Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. Lisa Laser Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 104. Lisa Laser Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Lisa Laser Main Business
Table 106. Lisa Laser Latest Developments
Table 107. Medifocus Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. Medifocus Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 109. Medifocus Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Medifocus Main Business
Table 111. Medifocus Latest Developments
Table 112. Neotrac Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. Neotrac Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 114. Neotrac Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Neotrac Main Business
Table 116. Neotrac Latest Developments
Table 117. ProArc Medical LTD Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 119. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. ProArc Medical LTD Main Business
Table 121. ProArc Medical LTD Latest Developments
Table 122. Urotech GMBH Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. Urotech GMBH Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 124. Urotech GMBH Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Urotech GMBH Main Business
Table 126. Urotech GMBH Latest Developments
Table 1. Benign Prostatic Hyperplasia Devices Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Benign Prostatic Hyperplasia Devices Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Transurethral Resection of the Prostate (TURP)
Table 4. Major Players of Transurethral Microwave Therapy (TUMT)
Table 5. Major Players of Transurethral Needle Ablation of the Prostate (TUNA)
Table 6. Major Players of Laser Surgery
Table 7. Major Players of Prostatic Stenting
Table 8. Major Players of Others
Table 9. Global Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 10. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Table 11. Global Benign Prostatic Hyperplasia Devices Revenue by Type (2019-2024) & ($ million)
Table 12. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2019-2024)
Table 13. Global Benign Prostatic Hyperplasia Devices Sale Price by Type (2019-2024) & (USD/Unit)
Table 14. Global Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 15. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Table 16. Global Benign Prostatic Hyperplasia Devices Revenue by Application (2019-2024)
Table 17. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application (2019-2024)
Table 18. Global Benign Prostatic Hyperplasia Devices Sale Price by Application (2019-2024) & (USD/Unit)
Table 19. Global Benign Prostatic Hyperplasia Devices Sales by Company (2019-2024) & (K Units)
Table 20. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Company (2019-2024)
Table 21. Global Benign Prostatic Hyperplasia Devices Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Company (2019-2024)
Table 23. Global Benign Prostatic Hyperplasia Devices Sale Price by Company (2019-2024) & (USD/Unit)
Table 24. Key Manufacturers Benign Prostatic Hyperplasia Devices Producing Area Distribution and Sales Area
Table 25. Players Benign Prostatic Hyperplasia Devices Products Offered
Table 26. Benign Prostatic Hyperplasia Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Benign Prostatic Hyperplasia Devices Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Benign Prostatic Hyperplasia Devices Sales Market Share Geographic Region (2019-2024)
Table 31. Global Benign Prostatic Hyperplasia Devices Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Benign Prostatic Hyperplasia Devices Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Country/Region (2019-2024)
Table 35. Global Benign Prostatic Hyperplasia Devices Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024) & (K Units)
Table 38. Americas Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2019-2024)
Table 39. Americas Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2019-2024)
Table 41. Americas Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 42. Americas Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 43. APAC Benign Prostatic Hyperplasia Devices Sales by Region (2019-2024) & (K Units)
Table 44. APAC Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2019-2024)
Table 45. APAC Benign Prostatic Hyperplasia Devices Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Benign Prostatic Hyperplasia Devices Revenue Market Share by Region (2019-2024)
Table 47. APAC Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 48. APAC Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 49. Europe Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024) & (K Units)
Table 50. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2019-2024)
Table 51. Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2019-2024)
Table 53. Europe Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 54. Europe Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 55. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Country (2019-2024) & (K Units)
Table 56. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Type (2019-2024) & (K Units)
Table 60. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales by Application (2019-2024) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Benign Prostatic Hyperplasia Devices
Table 62. Key Market Challenges & Risks of Benign Prostatic Hyperplasia Devices
Table 63. Key Industry Trends of Benign Prostatic Hyperplasia Devices
Table 64. Benign Prostatic Hyperplasia Devices Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Benign Prostatic Hyperplasia Devices Distributors List
Table 67. Benign Prostatic Hyperplasia Devices Customer List
Table 68. Global Benign Prostatic Hyperplasia Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 69. Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Benign Prostatic Hyperplasia Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Americas Benign Prostatic Hyperplasia Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Benign Prostatic Hyperplasia Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 73. APAC Benign Prostatic Hyperplasia Devices Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Benign Prostatic Hyperplasia Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Europe Benign Prostatic Hyperplasia Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 77. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2025-2030) & (K Units)
Table 81. Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Lumenis Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 83. Lumenis Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 84. Lumenis Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Lumenis Main Business
Table 86. Lumenis Latest Developments
Table 87. Olympus corporation Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 88. Olympus corporation Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 89. Olympus corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Olympus corporation Main Business
Table 91. Olympus corporation Latest Developments
Table 92. Urologix Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. Urologix Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 94. Urologix Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Urologix Main Business
Table 96. Urologix Latest Developments
Table 97. Boston Scientific corporation Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 99. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Boston Scientific corporation Main Business
Table 101. Boston Scientific corporation Latest Developments
Table 102. Lisa Laser Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. Lisa Laser Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 104. Lisa Laser Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Lisa Laser Main Business
Table 106. Lisa Laser Latest Developments
Table 107. Medifocus Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. Medifocus Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 109. Medifocus Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Medifocus Main Business
Table 111. Medifocus Latest Developments
Table 112. Neotrac Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. Neotrac Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 114. Neotrac Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Neotrac Main Business
Table 116. Neotrac Latest Developments
Table 117. ProArc Medical LTD Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 119. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. ProArc Medical LTD Main Business
Table 121. ProArc Medical LTD Latest Developments
Table 122. Urotech GMBH Basic Information, Benign Prostatic Hyperplasia Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. Urotech GMBH Benign Prostatic Hyperplasia Devices Product Portfolios and Specifications
Table 124. Urotech GMBH Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Urotech GMBH Main Business
Table 126. Urotech GMBH Latest Developments
LIST OF FIGURES
Figure 1. Picture of Benign Prostatic Hyperplasia Devices
Figure 2. Benign Prostatic Hyperplasia Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Benign Prostatic Hyperplasia Devices Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Benign Prostatic Hyperplasia Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Benign Prostatic Hyperplasia Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Transurethral Resection of the Prostate (TURP)
Figure 10. Product Picture of Transurethral Microwave Therapy (TUMT)
Figure 11. Product Picture of Transurethral Needle Ablation of the Prostate (TUNA)
Figure 12. Product Picture of Laser Surgery
Figure 13. Product Picture of Prostatic Stenting
Figure 14. Product Picture of Others
Figure 15. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2023
Figure 16. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2019-2024)
Figure 17. Benign Prostatic Hyperplasia Devices Consumed in Hospitals and Clinics
Figure 18. Global Benign Prostatic Hyperplasia Devices Market: Hospitals and Clinics (2019-2024) & (K Units)
Figure 19. Benign Prostatic Hyperplasia Devices Consumed in Ambulatory Surgical Centers(ASC)
Figure 20. Global Benign Prostatic Hyperplasia Devices Market: Ambulatory Surgical Centers(ASC) (2019-2024) & (K Units)
Figure 21. Benign Prostatic Hyperplasia Devices Consumed in Home
Figure 22. Global Benign Prostatic Hyperplasia Devices Market: Home (2019-2024) & (K Units)
Figure 23. Benign Prostatic Hyperplasia Devices Consumed in Others
Figure 24. Global Benign Prostatic Hyperplasia Devices Market: Others (2019-2024) & (K Units)
Figure 25. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2023)
Figure 26. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application in 2023
Figure 27. Benign Prostatic Hyperplasia Devices Sales Market by Company in 2023 (K Units)
Figure 28. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Company in 2023
Figure 29. Benign Prostatic Hyperplasia Devices Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Company in 2023
Figure 31. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Benign Prostatic Hyperplasia Devices Sales 2019-2024 (K Units)
Figure 34. Americas Benign Prostatic Hyperplasia Devices Revenue 2019-2024 ($ Millions)
Figure 35. APAC Benign Prostatic Hyperplasia Devices Sales 2019-2024 (K Units)
Figure 36. APAC Benign Prostatic Hyperplasia Devices Revenue 2019-2024 ($ Millions)
Figure 37. Europe Benign Prostatic Hyperplasia Devices Sales 2019-2024 (K Units)
Figure 38. Europe Benign Prostatic Hyperplasia Devices Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue 2019-2024 ($ Millions)
Figure 41. Americas Benign Prostatic Hyperplasia Devices Sales Market Share by Country in 2023
Figure 42. Americas Benign Prostatic Hyperplasia Devices Revenue Market Share by Country in 2023
Figure 43. Americas Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Figure 44. Americas Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Figure 45. United States Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Benign Prostatic Hyperplasia Devices Sales Market Share by Region in 2023
Figure 50. APAC Benign Prostatic Hyperplasia Devices Revenue Market Share by Regions in 2023
Figure 51. APAC Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Figure 52. APAC Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Figure 53. China Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Country in 2023
Figure 61. Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Country in 2023
Figure 62. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Figure 63. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Figure 64. Germany Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Figure 73. Egypt Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia Devices in 2023
Figure 79. Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
Figure 80. Industry Chain Structure of Benign Prostatic Hyperplasia Devices
Figure 81. Channels of Distribution
Figure 82. Global Benign Prostatic Hyperplasia Devices Sales Market Forecast by Region (2025-2030)
Figure 83. Global Benign Prostatic Hyperplasia Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Benign Prostatic Hyperplasia Devices Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Benign Prostatic Hyperplasia Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Benign Prostatic Hyperplasia Devices Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Benign Prostatic Hyperplasia Devices Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Benign Prostatic Hyperplasia Devices
Figure 2. Benign Prostatic Hyperplasia Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Benign Prostatic Hyperplasia Devices Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Benign Prostatic Hyperplasia Devices Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Benign Prostatic Hyperplasia Devices Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Transurethral Resection of the Prostate (TURP)
Figure 10. Product Picture of Transurethral Microwave Therapy (TUMT)
Figure 11. Product Picture of Transurethral Needle Ablation of the Prostate (TUNA)
Figure 12. Product Picture of Laser Surgery
Figure 13. Product Picture of Prostatic Stenting
Figure 14. Product Picture of Others
Figure 15. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2023
Figure 16. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2019-2024)
Figure 17. Benign Prostatic Hyperplasia Devices Consumed in Hospitals and Clinics
Figure 18. Global Benign Prostatic Hyperplasia Devices Market: Hospitals and Clinics (2019-2024) & (K Units)
Figure 19. Benign Prostatic Hyperplasia Devices Consumed in Ambulatory Surgical Centers(ASC)
Figure 20. Global Benign Prostatic Hyperplasia Devices Market: Ambulatory Surgical Centers(ASC) (2019-2024) & (K Units)
Figure 21. Benign Prostatic Hyperplasia Devices Consumed in Home
Figure 22. Global Benign Prostatic Hyperplasia Devices Market: Home (2019-2024) & (K Units)
Figure 23. Benign Prostatic Hyperplasia Devices Consumed in Others
Figure 24. Global Benign Prostatic Hyperplasia Devices Market: Others (2019-2024) & (K Units)
Figure 25. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2023)
Figure 26. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application in 2023
Figure 27. Benign Prostatic Hyperplasia Devices Sales Market by Company in 2023 (K Units)
Figure 28. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Company in 2023
Figure 29. Benign Prostatic Hyperplasia Devices Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Company in 2023
Figure 31. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Benign Prostatic Hyperplasia Devices Sales 2019-2024 (K Units)
Figure 34. Americas Benign Prostatic Hyperplasia Devices Revenue 2019-2024 ($ Millions)
Figure 35. APAC Benign Prostatic Hyperplasia Devices Sales 2019-2024 (K Units)
Figure 36. APAC Benign Prostatic Hyperplasia Devices Revenue 2019-2024 ($ Millions)
Figure 37. Europe Benign Prostatic Hyperplasia Devices Sales 2019-2024 (K Units)
Figure 38. Europe Benign Prostatic Hyperplasia Devices Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue 2019-2024 ($ Millions)
Figure 41. Americas Benign Prostatic Hyperplasia Devices Sales Market Share by Country in 2023
Figure 42. Americas Benign Prostatic Hyperplasia Devices Revenue Market Share by Country in 2023
Figure 43. Americas Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Figure 44. Americas Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Figure 45. United States Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Benign Prostatic Hyperplasia Devices Sales Market Share by Region in 2023
Figure 50. APAC Benign Prostatic Hyperplasia Devices Revenue Market Share by Regions in 2023
Figure 51. APAC Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Figure 52. APAC Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Figure 53. China Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Country in 2023
Figure 61. Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Country in 2023
Figure 62. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Figure 63. Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Figure 64. Germany Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2019-2024)
Figure 73. Egypt Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Benign Prostatic Hyperplasia Devices Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia Devices in 2023
Figure 79. Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
Figure 80. Industry Chain Structure of Benign Prostatic Hyperplasia Devices
Figure 81. Channels of Distribution
Figure 82. Global Benign Prostatic Hyperplasia Devices Sales Market Forecast by Region (2025-2030)
Figure 83. Global Benign Prostatic Hyperplasia Devices Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Benign Prostatic Hyperplasia Devices Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Benign Prostatic Hyperplasia Devices Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Benign Prostatic Hyperplasia Devices Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Benign Prostatic Hyperplasia Devices Revenue Market Share Forecast by Application (2025-2030)
